Literature DB >> 22855154

Intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) in a patient with left breast cancer and pectus excavatum.

Ricardo Cendales1, Jaider Vasquez, Juan Carlos Arbelaez, Ivan Bobadilla, Ricardo Espanol, Felipe Torres, Armando Gaitan.   

Abstract

INTRODUCTION: Pectus excavatum is a frequent anomaly. It represents a challenge for adjuvant radiotherapy in the conservative treatment of breast cancer. Primary objective of this study is to compare dosimetric outcomes, normal tissue complication probability (NTCP), and integral dose using four radiation techniques. Secondary objective is to describe acute toxicity and setup errors. METHODS AND MATERIALS: A 57-year-old female patient with an inner quadrant, left breast, ductal carcinoma in situ, was identified. Whole breast was prescribed with 50 Gy in 25 fractions. Boost planning target volume (PTV) was prescribed with 60 Gy in 30 fractions for sequential boost (SB) plans or 57.5 Gy in 25 fractions in the simultaneous integrated boost (SIB) plan. All plans were normalized to deliver 47.5 Gy to 95 % of the breast PTV. Daily image-guided radiotherapy (IGRT) was performed. Setup deviations were described.
RESULTS: Constraints were not accomplished for heart when using intensity modulated radiotherapy (IMRT) + SB or conformal radiotherapy with three photon fields and SB. Left lung constraint was not achieved by any of the techniques in comparison. IMRT + SIB and conformal photons and electrons + SB plan were closer to the objective. Integral doses were lower with IMRT for heart and ipsilateral lung; however, it were higher for contralateral breast and lung. Coverage and tumoral conformity indexes were similar for all techniques in comparison. Greater inhomogeneity was observed with the photons and electrons + SB. IMRT + SIB treatment was administered daily with grade I skin toxicity. The highest setup error was observed in Y direction.
CONCLUSION: Planning target volume coverage was similar with the four techniques. Homogeneity was superior with both IMRT plans. A good balance between dose constraints for organs at risk, PTV coverage, homogeneity, and NTCP was observed with IMRT + SIB. The documented daily setup error justifies the use of online IGRT.

Entities:  

Mesh:

Year:  2012        PMID: 22855154     DOI: 10.1007/s12094-012-0862-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  27 in total

1.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT).

Authors:  Louis Potters; Laurie E Gaspar; Brian Kavanagh; James M Galvin; Alan C Hartford; James M Hevezi; Patrick A Kupelian; Najeeb Mohiden; Michael A Samuels; Robert Timmerman; Prabhakar Tripuraneni; Maria T Vlachaki; Lei Xing; Seth A Rosenthal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

2.  [Helical tomotherapy: general methodology for clinical and dosimetric evaluation (national French project)].

Authors:  G Kantor; M-A Mahé; P Giraud; A Lisbona; J Caron; A Mazal
Journal:  Cancer Radiother       Date:  2006-10-19       Impact factor: 1.018

3.  Early experience of tomotherapy-based intensity-modulated radiotherapy for breast cancer treatment.

Authors:  H O'Donnell; K Cooke; N Walsh; P N Plowman
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-02-26       Impact factor: 4.126

Review 4.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

5.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

6.  Risk of cardiac death after adjuvant radiotherapy for breast cancer.

Authors:  Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

7.  Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years.

Authors:  Gillian C Barnett; Jennifer S Wilkinson; Anne M Moody; Charles B Wilson; Nicola Twyman; Gordon C Wishart; Neil G Burnet; Charlotte E Coles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-23       Impact factor: 7.038

8.  A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.

Authors:  Jean-Philippe Pignol; Ivo Olivotto; Eileen Rakovitch; Sandra Gardner; Katharina Sixel; Wayne Beckham; Thi Trinh Thuc Vu; Pauline Truong; Ida Ackerman; Lawrence Paszat
Journal:  J Clin Oncol       Date:  2008-02-19       Impact factor: 44.544

Review 9.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

10.  Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study.

Authors:  Rahul Roychoudhuri; David Robinson; Venkata Putcha; Jack Cuzick; Sarah Darby; Henrik Møller
Journal:  BMC Cancer       Date:  2007-01-15       Impact factor: 4.430

View more
  2 in total

1.  Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques.

Authors:  Moamen M O M Aly; Gerhard Glatting; Lennart Jahnke; Frederik Wenz; Yasser Abo-Madyan
Journal:  Radiat Oncol       Date:  2015-07-09       Impact factor: 3.481

2.  Is pectus excavatum a risk factor for radiation-induced lung disease in patients undergoing radiation therapy following breast-conserving surgery?

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Masaharu Hata; Kenichi Sakurai; Masahiro Okada
Journal:  Thorac Cancer       Date:  2018-12-18       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.